BioMarin sets stage early for hemophilia cure off-Broadway
(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six people in clinical trials) Cast members from the musical “Hemophilia:…
FDA approves BioMarin rare metabolic disorder drug, shares rise
(Reuters) – U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.…